David R Elmaleh

Inventor

Add to Portfolio

Stats

Details

Work History

Patent OwnerApplications FiledYear
SEROTON, INC.
2
2014
AZTHERAPIES, INC
2
2014
BIOSTREAM, INC.
1
1999
THEJMDE TRUST
1
1996
Zebra Pharmaceuticals
1
1994
ELMALEH, DAVID R.
2
2
2
2
2
1
2005
2006
2008
2009
2010
2013
BETH ISRAEL DEACONESS MEDICAL CENTER, INC.
2
1
2004
2010
ORGANIX, INC.
1
1
1993
1996
CHILDREN'S MEDICAL CENTER CORPORATION
2
2006
MASSACHUSETTS GENERAL HOSPITAL
1
2
5
1
1983
2004
2005
2006
The United States of America as represented by the United States Department of Energy
1
1983
ELMALEH, DAVID, DR.
1
3
1
1983
2004
2010
NORTHWESTERN UNIVERSITY
1
1
1996
1999
MOLECULAR INSIGHT PHARMACEUTICALS, INC.
1
2
1
1
2000
2005
2007
2008
PRESIDENT AND FELLOWS OF HARVARD COLLEGE
1
1
1993
1996
MERSANA THERAPEUTICS, INC.
2
1
2004
2010
THE GENERAL HOSPITAL CORPORATION
1
1
2
2
1
1
1
6
4
5
9
7
6
4
6
7
3
2
13
1
1993
1996
1997
1998
1999
2001
2003
2004
2005
2006
2007
2008
2009
2010
2012
2013
2014
2015
2016
2017
1QB INFORMATION TECHNOLOGIES INC.
2
2013
JMDE TRUST, THE
1
1
1
1994
1995
1996
NORTHEASTERN UNIVERSITY
1
1993

Inventor Addresses

AddressDuration
38 Hartman Rd.Feb 09, 10 - Aug 31, 10
38 Hartman Rd., Newton, MA 02159Dec 24, 96 - Dec 28, 04
85 E. India Row, Boston, MA 02110Apr 06, 99 - Sep 05, 00
Boston, MAFeb 10, 98 - Sep 04, 08
Boston, MA, USFeb 24, 09 - Oct 28, 14
Brookline, MAOct 14, 86 - Oct 14, 86
NEWTON, MA, USFeb 24, 11 - Oct 12, 17
Newton Center, MAJun 18, 85 - Jun 18, 85
Newton, MAFeb 20, 96 - Oct 30, 08
Newton, MA, USJun 23, 05 - Jan 30, 25
Newtown, MA, USJul 17, 14 - Aug 28, 18

Technology Profile

Technology Matters
A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 1
A23D: EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS 1
A61B: DIAGNOSIS; SURGERY; IDENTIFICATION 12

See more…

Patents / Publication

Patents / Publication #Year of Publication / IssuedTitleCitations
2025/0032,4052025HYDROGEL FORMULATIONS, VACCINES, AND METHODS OF USE THEREOF0
2024/0335,4162024GENOTYPE-SPECIFIC METHODS AND SYSTEMS FOR TREATMENT OF NEURODEGENERATIVE DISEASE0
2024/0226,3052024COMPOUNDS FOR TREATMENT OF TYPE 2 DIABETES0
2024/0082,2072024MACROPHAGES/MICROGLIA IN NEURO-INFLAMMATION ASSOCIATED WITH NEURODEGENERATIVE DISEASES0
2024/0067,6352024CROMOLYN DERIVATIVES AND USES THEREOF0

See more…


We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
> Upgrade to our Level for up to -1 portfolios!.